Tectonic Therapeutic (TECX) Competitors $23.41 -1.87 (-7.40%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$24.44 +1.04 (+4.42%) As of 03/3/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends TECX vs. WVE, EVO, SDGR, AMPH, APGE, IMCR, ARQT, KNSA, DYN, and SNDXShould you be buying Tectonic Therapeutic stock or one of its competitors? The main competitors of Tectonic Therapeutic include Wave Life Sciences (WVE), Evotec (EVO), Schrödinger (SDGR), Amphastar Pharmaceuticals (AMPH), Apogee Therapeutics (APGE), Immunocore (IMCR), Arcutis Biotherapeutics (ARQT), Kiniksa Pharmaceuticals (KNSA), Dyne Therapeutics (DYN), and Syndax Pharmaceuticals (SNDX). These companies are all part of the "pharmaceutical products" industry. Tectonic Therapeutic vs. Wave Life Sciences Evotec Schrödinger Amphastar Pharmaceuticals Apogee Therapeutics Immunocore Arcutis Biotherapeutics Kiniksa Pharmaceuticals Dyne Therapeutics Syndax Pharmaceuticals Wave Life Sciences (NASDAQ:WVE) and Tectonic Therapeutic (NASDAQ:TECX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, community ranking, profitability, valuation, analyst recommendations, media sentiment, risk and earnings. Does the media refer more to WVE or TECX? In the previous week, Wave Life Sciences had 10 more articles in the media than Tectonic Therapeutic. MarketBeat recorded 14 mentions for Wave Life Sciences and 4 mentions for Tectonic Therapeutic. Tectonic Therapeutic's average media sentiment score of 1.10 beat Wave Life Sciences' score of 0.67 indicating that Tectonic Therapeutic is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Wave Life Sciences 3 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tectonic Therapeutic 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better valuation and earnings, WVE or TECX? Tectonic Therapeutic has lower revenue, but higher earnings than Wave Life Sciences. Wave Life Sciences is trading at a lower price-to-earnings ratio than Tectonic Therapeutic, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWave Life Sciences$53.61M28.59-$57.51M-$1.11-9.05Tectonic TherapeuticN/AN/A$12.16M-$5.89-3.97 Which has more volatility & risk, WVE or TECX? Wave Life Sciences has a beta of -1.09, meaning that its stock price is 209% less volatile than the S&P 500. Comparatively, Tectonic Therapeutic has a beta of 2.62, meaning that its stock price is 162% more volatile than the S&P 500. Do institutionals and insiders believe in WVE or TECX? 89.7% of Wave Life Sciences shares are owned by institutional investors. Comparatively, 62.6% of Tectonic Therapeutic shares are owned by institutional investors. 29.1% of Wave Life Sciences shares are owned by company insiders. Comparatively, 9.2% of Tectonic Therapeutic shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts rate WVE or TECX? Wave Life Sciences currently has a consensus target price of $22.60, suggesting a potential upside of 124.88%. Tectonic Therapeutic has a consensus target price of $80.50, suggesting a potential upside of 243.87%. Given Tectonic Therapeutic's stronger consensus rating and higher possible upside, analysts plainly believe Tectonic Therapeutic is more favorable than Wave Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Wave Life Sciences 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.00Tectonic Therapeutic 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.17 Is WVE or TECX more profitable? Tectonic Therapeutic has a net margin of 0.00% compared to Wave Life Sciences' net margin of -66.50%. Tectonic Therapeutic's return on equity of -35.53% beat Wave Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Wave Life Sciences-66.50% -280.57% -52.90% Tectonic Therapeutic N/A -35.53%-31.97% Does the MarketBeat Community favor WVE or TECX? Wave Life Sciences received 356 more outperform votes than Tectonic Therapeutic when rated by MarketBeat users. However, 100.00% of users gave Tectonic Therapeutic an outperform vote while only 67.78% of users gave Wave Life Sciences an outperform vote. CompanyUnderperformOutperformWave Life SciencesOutperform Votes36467.78% Underperform Votes17332.22% Tectonic TherapeuticOutperform Votes8100.00% Underperform VotesNo Votes SummaryTectonic Therapeutic beats Wave Life Sciences on 10 of the 17 factors compared between the two stocks. Get Tectonic Therapeutic News Delivered to You Automatically Sign up to receive the latest news and ratings for TECX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TECX vs. The Competition Export to ExcelMetricTectonic TherapeuticBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$345.37M$3.09B$5.81B$8.43BDividend YieldN/A1.51%4.76%3.97%P/E Ratio-3.9728.6624.9419.24Price / SalesN/A404.01368.46110.22Price / CashN/A168.6838.0534.58Price / Book10.993.487.374.28Net Income$12.16M-$71.55M$3.18B$247.04M7 Day Performance-12.03%-5.00%-2.94%-3.26%1 Month Performance-51.24%-10.68%-6.84%-6.57%1 Year PerformanceN/A-22.37%12.61%4.01% Tectonic Therapeutic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TECXTectonic Therapeutic3.7137 of 5 stars$23.41-7.4%$80.50+243.9%N/A$345.37MN/A-3.97120Short Interest ↓Positive NewsWVEWave Life Sciences4.0502 of 5 stars$10.48-5.8%$22.22+112.0%+95.9%$1.60B$53.61M-9.44240EVOEvotec1.7741 of 5 stars$4.46+0.5%$5.93+33.0%-44.1%$1.58B$845.74M0.005,061Gap UpSDGRSchrödinger1.8846 of 5 stars$21.69-4.2%$32.11+48.0%-20.8%$1.58B$216.67M-9.27790Earnings ReportAnalyst RevisionAMPHAmphastar Pharmaceuticals4.372 of 5 stars$32.29+3.2%$50.33+55.9%-40.5%$1.55B$723.55M10.761,761APGEApogee Therapeutics2.9742 of 5 stars$33.37-3.4%$89.71+168.8%-15.7%$1.50BN/A-13.7991Earnings ReportAnalyst ForecastNews CoverageIMCRImmunocore1.3514 of 5 stars$29.99+0.2%$65.64+118.9%-57.2%$1.50B$249.43M-31.57320Analyst RevisionNews CoverageHigh Trading VolumeARQTArcutis Biotherapeutics3.3988 of 5 stars$12.39-4.8%$16.60+34.0%+9.0%$1.45B$59.61M-6.92150Earnings ReportAnalyst RevisionKNSAKiniksa Pharmaceuticals2.4032 of 5 stars$19.63-1.9%$36.60+86.4%-1.3%$1.42B$270.26M-140.20220Earnings ReportShort Interest ↑DYNDyne Therapeutics3.1939 of 5 stars$13.59-3.0%$49.91+267.2%-57.7%$1.38BN/A-3.82100Earnings ReportAnalyst RevisionSNDXSyndax Pharmaceuticals3.6184 of 5 stars$15.67-4.3%$36.20+131.0%-34.7%$1.34B$16M-4.32110Earnings ReportNews CoverageGap Up Related Companies and Tools Related Companies Wave Life Sciences Competitors Evotec Competitors Schrödinger Competitors Amphastar Pharmaceuticals Competitors Apogee Therapeutics Competitors Immunocore Competitors Arcutis Biotherapeutics Competitors Kiniksa Pharmaceuticals Competitors Dyne Therapeutics Competitors Syndax Pharmaceuticals Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TECX) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tectonic Therapeutic Please log in to your account or sign up in order to add this asset to your watchlist. Share Tectonic Therapeutic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TECX Stock Alerts